Valuation: Fusen Pharmaceutical Company Limited

Market Cap 566M 665M 84.81M 76.85M 71.09M 64.14M 121M 8B 125M 854M 339M 4.27B 318M 312M 13.56B P/E 2024
-2.95x
P/E 2025 -45.1x
Enterprise Value 788M 926M 118M 107M 98.96M 89.29M 168M 11.13B 174M 1.19B 471M 5.95B 443M 434M 18.88B EV / Sales 2024
2.83x
EV / Sales 2025 2.76x
Free-Float
26.11%
Yield 2024 *
-
Yield 2025 -
1 day-3.23%
1 week-9.09%
Current month-12.62%
1 month-5.26%
3 months-16.67%
6 months-23.08%
Current year+12.50%
1 week 0.9
Extreme 0.9
0.95
1 month 0.76
Extreme 0.765
1.03
Current year 0.67
Extreme 0.67
1.44
1 year 0.67
Extreme 0.67
1.44
3 years 0.24
Extreme 0.235
1.75
5 years 0.24
Extreme 0.235
2.54
10 years 0.24
Extreme 0.235
20
Manager TitleAgeSince
Director of Finance/CFO 48 2019-04-17
Investor Relations Contact 40 2013-01-17
Corporate Secretary 36 2024-09-29
Director TitleAgeSince
Director/Board Member 58 2019-04-14
Director/Board Member 49 2025-09-29
Director/Board Member 63 2017-04-06
Date Insider Type Main position Quantity % Market Cap. Importance
4/19/24 Other

Chairman

650,000 0.0867%
4/18/24 Other

Chairman

240,000 0.0320%
4/18/24 Other

Chairman

240,000 0.0320%
Change 5-day change 1-year change 3-year change Capi.($)
-3.23%-9.09%+9.76%-37.06% 87.65M
+1.12%+6.58%+41.08%+135.52% 1,271B
+0.85%+3.69%+46.69%+94.01% 683B
+0.13%+1.29%+27.03%+112.84% 520B
-0.44%+3.32%+39.36%+70.94% 389B
+0.51%+0.78%+59.13%+44.32% 362B
-0.12%-0.04%+28.04%+59.86% 304B
+0.37%-0.43%+3.43%+38.57% 286B
-0.19%+1.17%+38.63%+74.65% 253B
+0.07%+0.67%+34.19%+124.22% 208B
Average -0.07%+0.95%+32.73%+71.79% 428B
Weighted average by Cap. +0.52%+2.67%+37.71%+96.53%

Financials

2024 2025
Net sales 326M 383M 48.84M 44.26M 40.94M 36.94M 69.61M 4.61B 72.06M 492M 195M 2.46B 183M 179M 7.81B 273M 321M 40.95M 37.11M 34.33M 30.97M 58.36M 3.86B 60.42M 412M 164M 2.06B 154M 150M 6.55B
Net income -189M -222M -28.28M -25.63M -23.71M -21.39M -40.31M -2.67B -41.73M -285M -113M -1.42B -106M -104M -4.52B -11.78M -13.85M -1.77M -1.6M -1.48M -1.34M -2.52M -166M -2.6M -17.78M -7.05M -88.92M -6.62M -6.48M -282M
Net Debt 367M 432M 55.02M 49.86M 46.11M 41.61M 78.41M 5.19B 81.17M 554M 220M 2.77B 206M 202M 8.8B 222M 261M 33.26M 30.14M 27.88M 25.15M 47.4M 3.14B 49.07M 335M 133M 1.68B 125M 122M 5.32B
Projected Income Statement - Annual - Fusen Pharmaceutical Company Limited
Logo Fusen Pharmaceutical Company Limited
Fusen Pharmaceutical Co Ltd is a company mainly engaged in the cultivation of Chinese herbal medicine, pharmaceutical research and development, and sales. The Company's main business is the sales of Shuanghuanglian Oral Solutions, Shuanghuanglian Injections and other pharmaceutical products. The Company is also engaged in the research, production, and sales of various proprietary Chinese medicine and western medicine products for treating cold, fever, cardiovascular diseases and anemia. The Company mainly conducts business in the domestic market.
Employees
817
Date Price Change Volume
26-11-13 HK$0.9000 -3.23% 0
26-11-12 HK$0.9300 0.00% 0
26-11-11 HK$0.9300 -2.11% 0
26-11-10 HK$0.9500 0.00% 0
26-11-09 HK$0.9500 -4.04% 6,000
  1. Stock Market
  2. Stocks
  3. 1652 Stock